Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
Sophie C. Cazanave, Alexei A. Podtelezhnikov, Kristian Jensen, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Past, present and future perspectives in nonalcoholic fatty liver disease
Arun J. Sanyal
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 6, pp. 377-386
Closed Access | Times Cited: 465
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
Stefano Romeo, Arun J. Sanyal, Luca Valenti
Cell Metabolism (2020) Vol. 31, Iss. 1, pp. 35-45
Open Access | Times Cited: 175
A Systematic Review of Animal Models of NAFLD Finds High‐Fat, High‐Fructose Diets Most Closely Resemble Human NAFLD
Yu Ri Im, Harriet Hunter, Dana de Gracia Hahn, et al.
Hepatology (2021) Vol. 74, Iss. 4, pp. 1884-1901
Open Access | Times Cited: 120
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Shuang Wang, Scott L. Friedman
Science Translational Medicine (2023) Vol. 15, Iss. 716
Open Access | Times Cited: 55
Immunopathobiology and therapeutic targets related to cytokines in liver diseases
Yong He, Seonghwan Hwang, Yeni Ait Ahmed, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 18-37
Open Access | Times Cited: 107
The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
Divya P. Kumar, Rebecca Caffrey, Jonathon Marioneaux, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 98
Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease
Vincenzo Musolino, Micaela Gliozzi, Federica Scarano, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 77
Dietary carbohydrates and fatty liver disease
Sally Chiu, Kathleen Mulligan, Jean‐Marc Schwarz
Current Opinion in Clinical Nutrition & Metabolic Care (2018) Vol. 21, Iss. 4, pp. 277-282
Closed Access | Times Cited: 62
Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis
Munkhzul Ganbold, Yohei Owada, Yusuke Ozawa, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin‐Like Phospholipase Domain Containing 3–Mediated Acceleration of Steatohepatitis
Bubu A. Banini, Divya P. Kumar, Sophie C. Cazanave, et al.
Hepatology (2020) Vol. 73, Iss. 4, pp. 1290-1306
Open Access | Times Cited: 54
Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities
Richard Radun, Michael Trauner
Seminars in Liver Disease (2021) Vol. 41, Iss. 04, pp. 461-475
Open Access | Times Cited: 51
Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways
Yanyan Wang, Yunling Tai, Derrick Zhao, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 210-210
Open Access | Times Cited: 48
Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin
Marco Raffaele, Kristína Kovačovicová, Jan Fröhlich, et al.
Cell Communication and Signaling (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 47
Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis
Helene M. Ægidius, Sanne Skovgård Veidal, Michael Feigh, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 47
Changes of gut microbiota during silybin‐mediated treatment of high‐fat diet‐induced non‐alcoholic fatty liver disease in mice
Xiuxia Li, Yanping Wang, Yilan Xing, et al.
Hepatology Research (2019) Vol. 50, Iss. 1, pp. 5-14
Closed Access | Times Cited: 46
MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives
Michael Karin, Ju Youn Kim
Molecular Oncology (2024)
Open Access | Times Cited: 5
hnRNPU/TrkB Defines a Chromatin Accessibility Checkpoint for Liver Injury and Nonalcoholic Steatohepatitis Pathogenesis
Jing Xiong, Tongyu Liu, Lin Mi, et al.
Hepatology (2019) Vol. 71, Iss. 4, pp. 1228-1246
Open Access | Times Cited: 40
Treatment with cinnamaldehyde reduces the visceral adiposity and regulates lipid metabolism, autophagy and endoplasmic reticulum stress in the liver of a rat model of early obesity
Jessika Geisebel Oliveira Neto, Silvia Karl Boechat, Juliana Santos Romão, et al.
The Journal of Nutritional Biochemistry (2019) Vol. 77, pp. 108321-108321
Closed Access | Times Cited: 39
Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease
Sandra Steensels, Jixuan Qiao, Baran A. Ersoy
Metabolites (2020) Vol. 10, Iss. 7, pp. 283-283
Open Access | Times Cited: 39
Nanoparticle size and chemical modification play a crucial role in the interaction of nano gold with the brain: extent of accumulation and toxicity
Nouf N. Mahmoud, Abdulrahim Albasha, Suhair Hikmat, et al.
Biomaterials Science (2020) Vol. 8, Iss. 6, pp. 1669-1682
Closed Access | Times Cited: 33
Insulin dysregulation drives mitochondrial cholesterol metabolite accumulation: initiating hepatic toxicity in nonalcoholic fatty liver disease
Kei Minowa, Daniel Rodríguez‐Agudo, Mitsuyoshi Suzuki, et al.
Journal of Lipid Research (2023) Vol. 64, Iss. 5, pp. 100363-100363
Open Access | Times Cited: 11
Ancestral bisphenol A exposure led to nonalcoholic fatty liver disease and sex-specific alterations in proline and bile metabolism pathways in the liver
Sourav Chakraborty, Santosh Anand, Muhammad Numan, et al.
Environmental Toxicology and Chemistry (2025)
Closed Access
Gene Expression and DNA Methylation Alterations in the Glycine N-Methyltransferase Gene in Diet-Induced Nonalcoholic Fatty Liver Disease-Associated Carcinogenesis
Barbara Borowa‐Mazgaj, Aline de Conti, Volodymyr Tryndyak, et al.
Toxicological Sciences (2019) Vol. 170, Iss. 2, pp. 273-282
Open Access | Times Cited: 33
Second-Harmonic Generated Quantifiable Fibrosis Parameters Provide Signatures for Disease Progression and Regression in Nonalcoholic Fatty Liver Disease
Nicole D. Ng, Dean Tai, Yayun Ren, et al.
Clinical Pathology (2023) Vol. 16
Open Access | Times Cited: 10
The preventive effect of liraglutide on the lipotoxic liver injury via increasing autophagy
Yini He, Na Ao, Jing Yang, et al.
Annals of Hepatology (2019) Vol. 19, Iss. 1, pp. 44-52
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top